[go: up one dir, main page]

DE602005008578D1 - (poly)aminoacetamidderivate von epipodophyllotoxin, verfahren zu deren herstellung und deren anwendungen in der therapie als antikrebsmittel - Google Patents

(poly)aminoacetamidderivate von epipodophyllotoxin, verfahren zu deren herstellung und deren anwendungen in der therapie als antikrebsmittel

Info

Publication number
DE602005008578D1
DE602005008578D1 DE602005008578T DE602005008578T DE602005008578D1 DE 602005008578 D1 DE602005008578 D1 DE 602005008578D1 DE 602005008578 T DE602005008578 T DE 602005008578T DE 602005008578 T DE602005008578 T DE 602005008578T DE 602005008578 D1 DE602005008578 D1 DE 602005008578D1
Authority
DE
Germany
Prior art keywords
lotoxine
epipodophyl
therapy
poly
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005008578T
Other languages
English (en)
Inventor
Thierry Imbert
Yves Guminski
Jean-Marc Barret
Anna Kruczinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of DE602005008578D1 publication Critical patent/DE602005008578D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602005008578T 2004-04-16 2005-04-14 (poly)aminoacetamidderivate von epipodophyllotoxin, verfahren zu deren herstellung und deren anwendungen in der therapie als antikrebsmittel Expired - Lifetime DE602005008578D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0404053A FR2869035B1 (fr) 2004-04-16 2004-04-16 Derives (poly)aminoalkylaminoacetamide d'epipodophyllotoxine leur procede de preparation et leurs applications en therapeutique comme agent anticancereux
PCT/IB2005/001268 WO2005100363A1 (en) 2004-04-16 2005-04-14 (poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agents

Publications (1)

Publication Number Publication Date
DE602005008578D1 true DE602005008578D1 (de) 2008-09-11

Family

ID=34944659

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005008578T Expired - Lifetime DE602005008578D1 (de) 2004-04-16 2005-04-14 (poly)aminoacetamidderivate von epipodophyllotoxin, verfahren zu deren herstellung und deren anwendungen in der therapie als antikrebsmittel

Country Status (24)

Country Link
US (3) US7846926B2 (de)
EP (1) EP1742952B1 (de)
JP (1) JP4876070B2 (de)
CN (1) CN1946727B (de)
AR (1) AR048607A1 (de)
AT (1) ATE402938T1 (de)
AU (1) AU2005233382C1 (de)
BR (1) BRPI0509912B8 (de)
CA (1) CA2562617C (de)
CY (1) CY1108444T1 (de)
DE (1) DE602005008578D1 (de)
DK (1) DK1742952T3 (de)
ES (1) ES2311985T3 (de)
FR (1) FR2869035B1 (de)
HR (1) HRP20080542T3 (de)
MX (1) MXPA06011886A (de)
MY (1) MY137712A (de)
PL (1) PL1742952T3 (de)
PT (1) PT1742952E (de)
RS (1) RS50628B (de)
SI (1) SI1742952T1 (de)
TW (1) TWI350288B (de)
WO (1) WO2005100363A1 (de)
ZA (1) ZA200609055B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2888849B1 (fr) * 2005-07-19 2007-10-05 Pierre Fabre Medicament Sa Procede de preparation de la 4b-amino-4'-demethyl-4-desoxypodophyllotoxine
FR2919287B1 (fr) * 2007-07-26 2012-10-12 Pf Medicament Nouveaux derives fluorescents de polyamines, leur procede de preparation et leurs applications en tant qu'outils de diagnostic dans le traitement des tumeurs cancereuses.
FR2921369B1 (fr) * 2007-09-25 2014-07-11 Pf Medicament Nouveau procede de preparation de derives (poly) aminoalkylaminoacetamide d'epipodophyllotoxine,utiles pour leurs applications en therapeutique comme agent anticancereux.
FR2921368B1 (fr) * 2007-09-25 2012-10-12 Pf Medicament Nouveau procede de synthese de derives anticancereux de (poly) aminoalkylaminoacetamide d'epipodophyllotoxine.
FR2935143B1 (fr) * 2008-08-19 2010-12-03 Pf Medicament Nouveaus derives (poly)aminoalkylaminoalkylamides, alkyl-urees, ou alkyl-sulfonamides d'epipodophyllotoxine, leur procede de preparation et leur application en therapeuthique comme agent cancereux
CN102325809B (zh) 2008-12-31 2014-04-09 陶氏环球技术有限责任公司 提高的前催化剂组合物和方法
US8288585B2 (en) 2008-12-31 2012-10-16 Dow Global Technologies Llc Procatalyst composition with substitute 1,2-phenylene aromatic diester internal donor and method
KR101801992B1 (ko) 2009-12-02 2017-11-27 더블유.알. 그레이스 앤드 캄파니-콘. 폴리프로필렌 제조를 위한 촉매 중 내부 공여체로서 3 및 4개의 원자로 브릿지된 디카르보네이트 화합물
MY183040A (en) * 2009-12-02 2021-02-08 Grace W R & Co Two atom bridged dicarbonate compounds as internal donors in catalysts for polypropylene manufacture
CN102234283B (zh) 2010-04-23 2013-06-12 湖北工业大学 4′-去甲基表鬼臼毒素衍生物及其合成方法和应用
US8673969B2 (en) * 2010-11-11 2014-03-18 Council Of Scientific & Industrial Research Substituted 4-β-acrylamidopodophyllotoxin congeners as antitumour antibiotics and the process for preparation thereof
FR2967675B1 (fr) 2010-11-24 2015-02-27 Pf Medicament Derives fluorescents de cyanines polyamines en tant que sonde de diagnostic
WO2015161745A1 (zh) * 2014-04-25 2015-10-29 中国医药工业研究总院 鬼臼毒素衍生物、其制备方法、药物组合物及应用
CN104926841A (zh) * 2015-06-30 2015-09-23 遵义医学院 青蒿琥酯与鬼臼毒素偶联物在抗白血病药物中的应用及制备方法
WO2018234574A1 (en) 2017-06-22 2018-12-27 Ygm Consult Sas Combination therapy for the treatment of cancer
CN113801129A (zh) * 2021-09-30 2021-12-17 大连民族大学 一种鬼臼毒素脂质衍生物、纳米载体及其制备方法和在肿瘤治疗中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6323884A (ja) * 1986-07-17 1988-02-01 Nippon Kayaku Co Ltd 新規ポドフイロトキシン誘導体
US5300500A (en) * 1989-02-23 1994-04-05 The University Of North Carolina At Chapel Hill 4 beta-amino podophyllotoxin analog compounds and methods
US5332811A (en) * 1989-09-12 1994-07-26 The University Of North Carolina At Chapel Hill Etopside analogs
CN1068330A (zh) * 1991-07-03 1993-01-27 国家医药管理局上海医药工业研究院 4-氮取代-4-脱氧-4′-去甲表鬼臼毒素衍生物及其合成方法
FR2725990B1 (fr) * 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
FR2742439B1 (fr) 1995-12-14 1998-03-06 Pf Medicament Procede de preparation de la 4'-demethylepipodophyllotoxine a partir de la podophyllotoxine
FR2810321B1 (fr) * 2000-06-20 2002-07-26 Adir Nouveaux derives de podophyllotoxine carbamate et thiocarbamate, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2005521729A (ja) * 2002-03-28 2005-07-21 カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ 抗癌剤として有用な新規４−β−１’’−（２’’−（置換ベンゾイル）アニリノ）ポドフィロトキシンアナログ
US6566393B1 (en) * 2002-06-21 2003-05-20 The University Of North Carolina At Chapel Hill Etoposide analogs and methods of use thereof
EP1603474B1 (de) 2003-02-14 2013-09-11 The Board Of Trustees Of The Leland Stanford Junior University Elektrisches operationssystem mit einheitlich verbesserten elektrischen feldern und minimalen kollateralschäden
EP1599485A2 (de) 2003-02-18 2005-11-30 Ranbaxy Laboratories, Ltd. Podophyllotoxinderivative als antitumormittel

Also Published As

Publication number Publication date
US20150368258A1 (en) 2015-12-24
US7846926B2 (en) 2010-12-07
DK1742952T3 (da) 2008-10-27
WO2005100363A8 (en) 2006-10-26
EP1742952A1 (de) 2007-01-17
AR048607A1 (es) 2006-05-10
BRPI0509912B8 (pt) 2021-05-25
CA2562617C (en) 2013-06-11
PL1742952T3 (pl) 2009-01-30
HK1095812A1 (en) 2007-05-18
AU2005233382A1 (en) 2005-10-27
TWI350288B (en) 2011-10-11
US9403840B2 (en) 2016-08-02
FR2869035A1 (fr) 2005-10-21
CN1946727B (zh) 2010-08-11
PT1742952E (pt) 2008-10-27
CN1946727A (zh) 2007-04-11
JP4876070B2 (ja) 2012-02-15
BRPI0509912A (pt) 2007-09-18
AU2005233382B2 (en) 2009-07-16
EP1742952B1 (de) 2008-07-30
FR2869035B1 (fr) 2006-07-14
CA2562617A1 (en) 2005-10-27
RS50628B (sr) 2010-06-30
WO2005100363A1 (en) 2005-10-27
TW200604191A (en) 2006-02-01
ES2311985T3 (es) 2009-02-16
MXPA06011886A (es) 2006-12-14
ZA200609055B (en) 2008-06-25
CY1108444T1 (el) 2014-04-09
MY137712A (en) 2009-02-27
HRP20080542T3 (en) 2008-12-31
US20110053967A1 (en) 2011-03-03
BRPI0509912B1 (pt) 2019-08-27
AU2005233382C1 (en) 2010-02-04
US9216989B2 (en) 2015-12-22
US20090170843A1 (en) 2009-07-02
JP2007532628A (ja) 2007-11-15
SI1742952T1 (sl) 2008-12-31
ATE402938T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
DE602005008578D1 (de) (poly)aminoacetamidderivate von epipodophyllotoxin, verfahren zu deren herstellung und deren anwendungen in der therapie als antikrebsmittel
DE602004029236D1 (de) Cyclische harnstoffderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung als kinaseinhibitoren
ATE332713T1 (de) Absorbierende polymerzusammensetzung, medizinische artikel und verfahren
DE50207522D1 (de) Neue dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
NO20055204D0 (no) Derivater av piperidinyl- og pipemzinylalkylkarbamater, fremgangsmater for fremstilling derav og anvendelse av de samme i terapi
DE602004022946D1 (de) 4-cyanopyrazol-3-carbonsäureamidderivate, herstellung und therapeutische anwendung davon
ATE395342T1 (de) 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung
BRPI0607198A2 (pt) composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica
DE60304599D1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
EP1651651A4 (de) Cucurbiturilderivate enthaltende nanopartikel, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung
DE602004013479D1 (de) Verzweigtes Polymer, Verfahren zu seiner Herstellung und seine Anwendungen
DE602004015600D1 (de) Neue imidazolderivative, deren herstellung und deren verwendung als medikament
ATE374172T1 (de) Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
DE602004003751D1 (de) Heterocyclische Oximderivate, Verfahren zu ihrer Herstellung und Verwendung in der Behandlung von Typ II Diabetes
ATE545644T1 (de) Benzimidazolderivate, diese enthaltende zusammensetzungen, herstellung davon und anwendungen davon i
DE602006005246D1 (de) Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung
DE602005011818D1 (de) Aminotropanderivate, deren herstellung und deren therapeutische verwendung
ATE503749T1 (de) Buttersäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
DE602004015050D1 (de) DMOS-Struktur und Verfahren zu deren Herstellung
DE602006016285D1 (de) Derivate von 4,5-diarylpyrrol, verfahren zu deren herstellung und deren verwendung in therapeutika
DE602005005355D1 (de) 9-Chloro-15-deoxyprostaglandinderivate, Verfahren zu ihrer Herstellung und deren Verwendung als Medikamente
DE602006018172D1 (de) Cyclische n-ä1,3,4ü-thiadiazol-2-yl-benzsulfonamide, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE344265T1 (de) Derivate von benzothiazin und benzothiadiazin, verfahren zu ihrer herstellung und pharmazeutische zubereitungen diese enthaltend
EP1749090A4 (de) Zelltherapieformulierungsverfahren und zusammensetzung
DE602005002138D1 (de) Pentensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und deren therapeutische anwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition